Yoga and meditation can offer a simple, safe and low-cost solution for improving brain fitness, according to new research. Combined, they were found to be even more effective than what many consider to...
Law requiring dementia training for healthcare professionals is unprecedented, Alzheimer’s Association...
By
Lois A. Bowers
Aug 14, 2018
Healthcare professionals who treat adults in Massachusetts will be required to undergo training related to Alzheimer’s disease under a new law signed Thursday by Gov. Charlie Baker.
Study: Technology helps decrease antipsychotic use in residents with dementia
By
Lois A. Bowers
Mar 09, 2016
Use of touchscreen computers with interfaces tailored to residents’ interests and abilities can result in a clinically significant decrease in the use of antipsychotic drugs among those with dementia,...
Assisted living will help shape Louisiana’s dementia response plans
By
Kimberly Bonvissuto
Jun 06, 2024
Legislative action creating a coordinated response to Alzheimer’s and dementia in Louisiana is being called a “commendable” step toward addressing the needs of those affected by the disease. And...
Decision-making on antipsychotic medication use in assisted living needs system-level perspective: study
By
Kimberly Bonvissuto
Jan 25, 2023
Decisions on administering as-needed antipsychotic medications in assisted living/ residential care communities are based on attitudes, underlying morality and perceived expertise, requiring a system-level...
Act prioritizes fight against Alzheimer’s disease with state plan
By
Kimberly Bonvissuto
Sep 12, 2023
South Carolina’s adoption of a state Alzheimer’s plan is a “step forward,” according to senior living advocates.
Two Alzheimer’s drug trials halted
By
Lois A. Bowers
Mar 22, 2019
Two late-stage clinical trials of a drug for Alzheimer’s disease have been stopped because they aren’t likely to produce promising results, two companies involved with the research announced Thursday.
Providers identify 5 key areas for person-centered care of residents with dementia
By
Kimberly Bonvissuto
Nov 19, 2020
Several senior living companies were part of a roundtable that helped researchers identify five areas of change and developed person-centered practical solutions to address the unmet needs of people with...
FDA approves second drug for Alzheimer’s disease, despite safety concerns
Jan 06, 2023
The approval of lecanemab-irmb (Leqembi) comes after controversial approval in 2021 of aducanumab (Aduhelm), which met with criticism over concerns about that drug’s effectiveness, safety and pricing.
Antipsychotic prescribing increases in assisted living during pandemic: study
By
Kimberly Bonvissuto
Apr 11, 2022
The prescribing of antipsychotic medications in assisted living communities and nursing homes has increased by 1.5% since the beginning of the COVID-19 pandemic, according to a recent study.